1-1 of 1
Sean P. Bohen, MD, PhD
Close
Sort by
Journal Articles

The Number of CD25+ Tumor-Infiltrating Cells May Predict Clinical Response to Rituximab in Follicular Lymphoma Patients.

Christopher Y. Park, MD, PhD, Sean P. Bohen, MD, PhD, Ronald Levy, MD, Roger A. Warnke, MD, Yasodha Natkunam, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 748.
https://doi.org/10.1182/blood.V104.11.748.748
Published: 2004